PUBLISHER: Inkwood Research | PRODUCT CODE: 1240639
PUBLISHER: Inkwood Research | PRODUCT CODE: 1240639
The North America insulin patch pumps market is expected to register an 11.09% CAGR during the assessment period, 2023-2032. Growing healthcare expenditure and rising per capita income are expected to drive market growth in the region.
The North America insulin patch pumps market growth assessment includes an analysis of Canada and the United States. Canada boasts a wealth of internationally recognized diabetes researchers, building upon the remarkable legacy of the Canadian discovery of insulin many years ago. Through strategic collaboration with various partners and investments in health research, the Government of Canada remains committed to advancing the prevention, diagnosis, and treatment of all forms of diabetes.
Canada's contributions to advances in diabetes prevention and treatment are noteworthy, given that the government of Canada reports over 3 million people with diagnosed diabetes, and the prevalence rate has been increasing at an average rate of 3.3% per year after adjusting for the aging population. The growing prevalence of diabetes and rising investments in healthcare research and development are anticipated to propel the market growth during the forecast period.
Key market players include: Tandem Diabetes Care Inc, Insulet Corporation, Medtronic PLC, etc.